MedTrace Logo

Post Market ATS 3f® Aortic Bioprosthesis, Model 1000, Size 19mm

NCT01156272 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-08-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the ATS 3f® Aortic Bioprosthesis, Model 1000 (Equine Pericardial Bioprothesis) size 19mm in a patient population undergoing isolated aortic valve replacement of his/her native aortic valve, or replacement of a failed prosthesis.

Conditions

  • Heart Valve Diseases

Interventions

DEVICE

ATS Medical 3f® Aortic Bioprosthesis, Model 1000 19mm

Replacement aortic heart valve

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Mike Boulware, PhD · Medtronic

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156272 on ClinicalTrials.gov